All terms in BMONT

Label Id Description
three-dimensional spatial region BFO_0000028
site BFO_0000029
Intestinal Injury SCDO_1000433 [Damage inflicted on the intestine.]
zero-dimensional continuant fiat boundary BFO_0000147
one-dimensional spatial region BFO_0000026
zero-dimensional temporal region BFO_0000148
AKR1C3 OMIT_0036840
object aggregate BFO_0000027
metabolic process GO_0008152 [The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.]
flow cytometry assay OBI_0000916 [A cytometry assay in which an input cell population is put in solution, is passed by a laser, and optical sensors are used to detect scattering of the laser light and/or fluorescence of specific markers to count and characterize the particles in solution.]
mosaic loss of chromosome X measurement EFO_0022842 [It is the most common clonal somatic alteration in leukocytes of female individuals.]
spatiotemporal region BFO_0000011
trefoil factor 3 PR_000016276 [A protein that is a translation product of the human TFF3 gene or a 1:1 ortholog thereof.]
Human Epidermal Growth Factor Receptor 2 Measurement NCIT_C112312 [The determination of the amount of human epidermal growth factor receptor 2 present in a sample.]
hormone CHEBI_24621 [Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.]
tau deposition BMONT_0000121 [Tau deposition refers to the accumulation of abnormal tau protein aggregates in the brain, which is a characteristic feature of several neurodegenerative disorders, including Alzheimer's disease (AD), frontotemporal dementia (FTD), and certain forms of Parkinson's disease (PD), among others. In neuroimaging, techniques such as positron emission tomography (PET) using radioligands targeting tau can visualize and quantify tau deposition in the brain. These imaging methods enable researchers and clinicians to detect the presence of abnormal tau aggregates and assess their distribution and severity.]
mean diffusivity BMONT_0000122 [Mean diffusivity (MD) is a metric derived from diffusion-weighted magnetic resonance imaging (DW-MRI) data. It quantifies the average magnitude of water molecule diffusion within a particular tissue or region of interest. MD is calculated based on the diffusion tensor, which characterizes the rate and directionality of water diffusion in tissue. Unlike fractional anisotropy (FA), which measures the degree of diffusion directionality, MD represents the overall magnitude of diffusion regardless of direction.]
WWC3 OMIT_0043247
sleep duration EFO_0005271 [duration of sleep, measured either via a self-reporting questionnaire, interview or through obversation in a sleep lab]
sleep time EFO_0005274 [measurement of the time at which sleep begins]